IL10 and cancer: The purpose of this study was to quantitatively summarize the association between serum IL–10 overexpression and clinical outcomes in cancer patients, and thereby shed more light on the clinical value of IL–10 as a prognostic biomarker and therapeutic target for both solid and hematological malignances.